Limbic selectivity of clozapine [3]

Lancet

Volumn 350, Issue 9076, 1997, Pages 490-491

  Pilowsky, L S ^a   Mulligan, R S ^a   Acton, P D ^a   Ell, P J ^a   Costa, D C ^a   Kerwin, R W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; NEUROLEPTIC AGENT;

ADULT; CLINICAL ARTICLE; DRUG TARGETING; FEMALE; HUMAN; LETTER; LIMBIC CORTEX; MALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; TARGET ORGAN;

EID: 0030859144     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63079-6     Document Type: Article

References (5)

1. SJ Peroutka SH Snyder Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic and histaminergic receptors to clinical potency Am J Psychiatry 137 1980 1518 1522
2. 2 dopamine receptor occupancy in relation to antipsychotic drug effects: a double blind PET study of schizophrenic patients Biol Psychiatry 33 1993 227 235
3. 2 receptor occupancy in patients treated with classical neuroleptics and clozapine Arch Gen Psychiatry 49 1992 538 544
4. 2 dopamine receptor blockade hypothesis of schizophrenia Lancet 340 1992 199 202
5. 2 receptors in the human brain Eur J Pharmacol 223 1992 105 107